Peninsula cancer-fighting pioneer eyes North Carolina for $100M investment, 400 jobs

The Menlo Park company, which focuses on blood-based cancer tests, has raised more than $2 billion
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.